Morphic Medical

Statement from the German Diabetic Association (DDG) on the Termination of the “ENDO Trial” Study (FDA Study of the EndoBarrier in Patients with Type 2 Diabetes Mellitus)

Statement from the German Diabetic Association (DDG) on the Termination of the “ENDO Trial” Study (FDA Study of the EndoBarrier in Patients with Type 2 Diabetes Mellitus)

Statement from the German Diabetic Association (DDG) on the Termination of the “ENDO Trial” Study (FDA Study of the EndoBarrier in Patients with Type 2 Diabetes Mellitus)

On July 30, 2015, GI Dynamics (GID) announced that the clinical study (“Endo Trial”) conducted in the USA would be terminated with immediate effect.

Videos

Previous
Next

How RESET Works

Maintenance of Efficacy After RESET

BBC News Item

DJBL for the treatment of type 2 diabetes and obesity: EASD 2022